Lifecore Biomedical
LFCR
LFCR
76 hedge funds and large institutions have $203M invested in Lifecore Biomedical in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0.37% more ownership
Funds ownership: 67.02% → 67.39% (+0.37%)
6% less funds holding
Funds holding: 81 → 76 (-5)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
Holders
76
Holding in Top 10
7
Calls
$375K
Puts
$102K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$10.3M | |
| 3 | +$5.89M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.13M |
| 5 |
DA
DCF Advisers
Greenwich,
Connecticut
|
+$1.87M |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$1.6M | |
| 3 | -$743K | |
| 4 |
2C
272 Capital
Dallas,
Texas
|
-$707K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$502K |